Throughout the three-month program, recently discharged heart failure patients will use a wearable biosensor and accompanying app to track symptoms, manage medications and communicate with care teams. Biofourmis’ artificial intelligence-powered Biovitals Analytics Engine will continuously process patient data captured by the app to predict exacerbation of the patients’ cardiac conditions in advance and provide care teams with suggestions for early intervention.
The project is similar to another one currently in the works at the Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation. Announced in July, that study will use the Biovitals platform to determine how heart failure patients’ functional capacity and quality of life affect the drug approval process.
More articles on AI:
AI to have major effects on better-paid, higher-educated workers: 5 things to know
AI not likely to replace physicians, experts say
Novant Health deploys AI platform to predict, improve patient flow
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
